retatrutide fatty liver disease 𧬠BREAKTHROUGH IN HEALTH? Scientists have reported that Retatrutide, an investigational metabolic therapy, reduced liver fat by up to 82% in an early clinical study involving people with liver Mazdutide vs retatrutide: dual agonist
Description
Whilst neurobiological mechanisms suggest plausible pathways through which these medicines might influence appetite and reward processing, definitive evidence remains limited

Available from: Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al

After stopping the drug, approximately 97% clears within 30 days (five half-lives)

got questions

Theoretical analysis suggests complementary mechanisms with potential insulin resistance concerns
